Fibroids and Subfertility: A Systematic Review of Latest Evidence from international Societies

Authors

  • Alina Shirazi Department of Obstetrics and Gynaecology, Basildon Hospital, South and Mid-Essex Foundation Trust, Basildon, Essex, UK
  • Tokunbo Adeoye Department of Obstetrics and Gynaecology, Basildon Hospital, South and Mid-Essex Foundation Trust, Basildon, Essex, UK
  • Seema Bagtharia Department of Obstetrics and Gynaecology, Basildon Hospital, South and Mid-Essex Foundation Trust, Basildon, Essex, UK
  • Jitendra Jadhav Department of Obstetrics and Gynaecology, Basildon Hospital, South and Mid-Essex Foundation Trust, Basildon, Essex, UK
  • Sumi Garg Department of Obstetrics and Gynaecology, Colchester Hospital, UK
  • Humna Mian Faiz Rasul Sir Syed Medical College, Karachi, Pakistan
  • Fatima Shah Bedford Hospital, NHS Trust, Bedford, UK

DOI:

https://doi.org/10.54536/ajmsi.v4i1.3992

Keywords:

Fertility, Fibroids, Guidelines, Infertility, Leiomyomas, Uterine Fibroids

Abstract

Uterine fibroids (leiomyomas) are benign tumors of the uterus, commonly present among women of reproductive age, affecting fertility outcomes. This systematic review aims to gather the current evidence regarding the association between fibroids and subfertility. Additionally, this review aims to analyze national recommendations to conclude the best uterine fibroid treatment, while highlighting the optimal method of enhancing pregnancy rates. A thorough literature search was conducted to retrieve standard of practice guidelines across PubMed, Google Scholar, and MEDLINE databases. Further guidelines were also searched through relevant websites of obstetrics and gynecology associations. Hence, seven international clinical guidelines were retrieved. The findings state that fibroids can affect fertility through several mechanisms, such as modification of the uterine environment, and distortion of fallopian tubes and uterine cavity, leading to potential implantation and placentation failure. In addition, various fibroid management approaches, including medical treatments like surgical and minimally invasive interventions in women desiring future fertility, are investigated. Latest studies suggest that the amount, size, and location of fibroids impact fertility outcomes. All guidelines recommend that during the selection of a treatment method, personalized patient requirements like the preference for childbirth in the future should be taken into consideration. The number, size, and location of fibroids are critical elements to take into consideration. Globally, fibroid management with inexplicable infertility in women has limited empirical and standardized guidelines. Therefore, further research is crucial to understand the fundamental mechanisms and to establish effective management strategies for women with fibroids facing subfertility.

Downloads

Download data is not yet available.

References

Australia, R. (2020). New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Advice to Obstetricians and Gynaecologists, RANZCOG, Melbourne, Australia. https://ranzcog.edu.au/wp-content/uploads/Fibroids-in-Infertility.pdf

Baird, D. D., Dunon, D. B., Hill, M. C., Cousins, D., & Schectman, J. M. (2003). High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. American journal of obstetrics and gynecology, 188(1), 100-107. https://doi.org/10.1067/mob.2003.99

Brignardello-Petersen, R., & Guyatt, G. H. (2024). Assessing the Certainty of the Evidence in Systematic Reviews: Importance, Process, and Use. American Journal of Epidemiology, kwae, 332. https://doi.org/10.1093/aje/kwae332

Casini, M. L., Rossi, F., Agostini, R., & Unfer, V. (2006). Effects of the position of fibroids on fertility. Gynecological endocrinology, 22(2), 106-109. https://doi.org/10.1080/09513590600604673

Cramer, S. F., & Patel, A. (1990). The frequency of uterine leiomyomas. American journal of clinical pathology, 94(4), 435-438. https://doi.org/10.1093/ajcp/94.4.435

Donnez, J., & Jadoul, P. (2002). What are the implications of myomas on fertility? A need for a debate? Human reproduction, 17(6), 1424-1430. https://doi.org/10.1093/humrep/17.6.1424

Drayer, S. M., & Catherino, W. H. (2015). Prevalence, morbidity, and current medical management of uterine leiomyomas. International Journal of Gynecology & Obstetrics, 131(2), 117-122. https://doi.org/10.1016/j.ijgo.2015.04.051

Goerke, K., Valet, A., Holtermann, H., Raichle, G., & Dangl, S. (2014). Kurzlehrbuch Gynäkologie und Geburtshilfe. “ Elsevier, Urban & FischerVerlag”.

Gomez, E., Nguyen, M.-L. T., Fursevich, D., Macura, K., & Gupta, A. (2021). MRI-based pictorial review of the FIGO classification system for uterine fibroids. Abdominal Radiology, 46, 2146-2155. https://doi.org/10.1007/s00261-020-02882-z

Haddaway, N. R., Page, M. J., Pritchard, C. C., & McGuinness, L. A. (2022). PRISMA2020: An R package and Shiny app for producing PRISMA 2020‐compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell systematic reviews, 18(2), e1230. https://doi.org/10.1002/cl2.1230

Jeldu, M., Asres, T., Arusi, T., & Gutulo, M. G. (2021). Pregnancy Rate after Myomectomy and Associated Factors among Reproductive Age Women Who Had Myomectomy at Saint Paul’s Hospital Millennium Medical College, Addis Ababa: Retrospective Cross-Sectional Study. International journal of reproductive medicine, 2021(1), 6680112. https://doi.org/10.1155/2021/6680112

Khaund, A., & Lumsden, M. A. (2008). Impact of fibroids on reproductive function. Best practice & research Clinical obstetrics & gynaecology, 22(4), 749-760. https://doi.org/10.1016/j.bpobgyn.2008.01.009

Laparoscopists, A. A. o. G. (2012). AAGL practice report: practice guidelines for the diagnosis and management of submucous leiomyomas. Journal of minimally invasive gynecology, 19(2), 152-171. https://doi.org/10.1016/j.jmig.2011.09.005.

Lasmar, R. B., Barrozo, P. R. M., Dias, R., & de Oliveira, M. A. P. (2005). Submucous myomas: a new presurgical classification to evaluate the viability of hysteroscopic surgical treatment—preliminary report. Journal of minimally invasive gynecology, 12(4), 308-311. https://doi.org/10.1016/j.jmig.2005.05.014

Laughlin-Tommaso, S. K., Hesley, G. K., Hopkins, M. R., Brandt, K. R., Zhu, Y., & Stewart, E. A. (2017). Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids. International Journal of Gynecology & Obstetrics, 139(2), 143-148. https://doi.org/10.1002/ijgo.12266

Mahdi, E. E. (2019). Fibroids and Infertility. European Medical Journal. https://doi.org/10.33590/emjreprohealth/10311354

Marret, H., Fritel, X., Ouldamer, L., Bendifallah, S., Brun, J.-L., De Jesus, I., Derrien, J., Giraudet, G., Kahn, V., & Koskas, M. (2012). Therapeutic management of uterine fibroid tumors: updated French guidelines. European Journal of Obstetrics & Gynecology and Reproductive Biology, 165(2), 156-164. https://doi.org/10.1016/j.ejogrb.2012.07.030

Michos, G., Dagklis, T., Papanikolaou, E., Tsakiridis, I., Oikonomou, K., Mamopoulos, A. M., Kalogiannidis, I. A., & Athanasiadis, A. (2023). Uterine Leiomyomas and Infertility: A Comparison of National and International Guidelines. Cureus, 15(12). https://doi.org/10.7759/cureus.50992

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & PRISMA Group, T. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine, 151(4), 264-269. https://doi.org/10.7326/0003-4819-151-4-200908180-00135

Mukhopadhaya, N., Asante, G. P., & Manyonda, I. T. (2007). Uterine fibroids: impact on fertility and pregnancy loss. Obstetrics, Gynaecology & Reproductive Medicine, 17(11), 311-317. https://doi.org/10.1016/j.ogrm.2007.08.005

Munro, M. G., Critchley, H. O., Broder, M. S., Fraser, I. S., & Disorders, F. W. G. o. M. (2011). FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. International Journal of Gynecology & Obstetrics, 113(1), 3-13. https://doi.org/10.1016/j.ijgo.2010.11.011

Peddada, S. D., Laughlin, S. K., Miner, K., Guyon, J.-P., Haneke, K., Vahdat, H. L., Semelka, R. C., Kowalik, A., Armao, D., & Davis, B. (2008). Growth of uterine leiomyomata among premenopausal black and white women. Proceedings of the National Academy of Sciences, 105(50), 19887-19892. https://doi.org/10.1073/pnas.0808188105

Penzias, A., Bendikson, K., Butts, S., Coutifaris, C., Falcone, T., Fossum, G., Gracia, C., Hansen, K., La Barbera, A., & Mersereau, J. (2017). Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertility and Sterility, 108(3), 416-425. https://doi.org/10.1016/j.fertnstert.2017.06.034

Pritts, E. A. (2001). Fibroids and infertility: a systematic review of the evidence. Obstetrical & gynecological survey, 56(8), 483-491. https://doi.org/10.1097/00006254-200108000-00022

Stamatellos, I., & Bontis, J. (2007). Hysteroscopic myomectomy. European Clinics in Obstetrics and Gynaecology, 3, 17-23. https://doi.org/10.1007/s11296-007-0061-1

Toprak, M., Ates, O., Ozsoy, A. Z., Bozkurt, N., Sezer Sondas, S., Cakmak, B., Yılmaz Dogru, H., Delibas, İ. B., & Demirturk, F. (2019). Analysis of estrogen and progesterone receptor gene polymorphisms in leiomyoma. Journal of Clinical Laboratory Analysis, 33(3), e22704. https://doi.org/10.1002/jcla.22704

Trust, B. F. (2021). Treatment Summary of Fibroids. http://www.britishfibroidtrust.org.uk/Fib_info/sot.php#:~:text=In%20most%20cases%2C%20fibroids%20do,how%20accessible%20the%20fibroids%20are.

Vilos, G. A., Allaire, C., Laberge, P.-Y., Leyland, N., Vilos, A. G., Murji, A., & Chen, I. (2015). The management of uterine leiomyomas. Journal of Obstetrics and Gynaecology Canada, 37(2), 157-178. https://doi.org/10.1016/S1701-2163(15)30338-8

Published

2025-03-04

How to Cite

Shirazi, A., Adeoye, T., Bagtharia, S., Jadhav, J., Garg, S., Rasul, H. M. F., & Shah, F. (2025). Fibroids and Subfertility: A Systematic Review of Latest Evidence from international Societies. American Journal of Medical Science and Innovation, 4(1), 74–83. https://doi.org/10.54536/ajmsi.v4i1.3992